Xeljanz Edges Humira Just a Bit for Real-World RA Patients, Study Suggests

Australian researchers perform 'target trial emulation' to compare popular drugs

Related Keywords

Australia ,Sydney ,New South Wales ,John Gever ,Tofacitinib Xeljanz ,Clairet Deakin ,Rheumatology Ltd ,Disease Activity Score ,Managing Editor ,